Answers are grounded in this paper and cite their sources.
Composite scaffolds enhance bone regeneration in maxillofacial defects, suggesting a new treatment approach.
Maxillofacial bone defects remain a complex clinical challenge due to their complex anatomy and limited regenerative capacity. In this study, a bioactive chitosan (CS) scaffold co-incorporated with nicotinamide mononucleotide (NMN) and naringin (Ng) was designed to stimulate osteogenesis and cellular metabolism for enhanced bone regeneration. Fourier-transform infrared analysis verified successful molecular integration of NMN and Ng within the chitosan framework, while scanning electron microscopy showed a uniformly porous surface favorable for stem-cell adhesion. Dental pulp stem cells (DPSCs) cultured on CS/NMN/Ng scaffolds exhibited enhanced cell proliferation, mitochondrial activity, and osteogenic differentiation compared with unmodified chitosan. At the cellular level, calcium deposition was markedly increased; molecular analysis confirmed up-regulated expression of Runx2, alkaline phosphatase (ALP), and type-I collagen. The bone regenerative capacity was further validated in a rat mandibular defect model, where micro-computed tomography and histological staining demonstrated near-complete closure of the defect with increased bone volume fraction and trabecular density after 8 weeks. Overall, the NMN-naringin-functionalized chitosan scaffold provides a metabolically active, osteoinductive microenvironment that promotes bone regeneration, indicating a translational potential for maxillofacial and craniofacial bone tissue engineering applications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: